Cargando…
Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform
Synuclein gamma (SNCG) is under consideration as a potential biomarker in cancer biology. Up to date four different SNCG variants are described. Due to growing evidence suggesting correlations between aberrant alternative splicing processes and cancer progression, we investigated the effects of peri...
Autores principales: | Schaal, Kathrin, Hirschfeld, Marc, Bronsert, Peter, Füllgraf, Hannah, Jäger, Markus, Herde, Bettina, Nöthling, Claudia, Mayer, Sebastian, Erbes, Thalia, Stickeler, Elmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673181/ https://www.ncbi.nlm.nih.gov/pubmed/26265438 |
Ejemplares similares
-
HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer
por: Hirschfeld, Marc, et al.
Publicado: (2015) -
Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker
por: Erbes, Thalia, et al.
Publicado: (2015) -
Exometabolom analysis of breast cancer cell lines: Metabolic signature
por: Willmann, Lucas, et al.
Publicado: (2015) -
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study
por: Berner, Kai, et al.
Publicado: (2021) -
Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
por: Ritter, Andrea, et al.
Publicado: (2019)